交易 Arcturus Therapeutics Holdings Inc - ARCT 差价合约

Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) develops RNA-based medicines using its proprietary lipid nanoparticle and self-amplifying mRNA platforms. The company’s pipeline includes vaccines, liver-targeted therapies, and respiratory treatments with partnerships across major global health organizations. Arcturus’s shares move with clinical trial progress, regulatory milestones, and investor sentiment toward the mRNA therapeutics sector.